AZTA vs DHR
AZTA: Azenta provides critical sample management and automated cold storage solutions that underpin life sciences research and clinical development. DHR: A premier global life sciences and diagnostics innovator that applies the Danaher Business System to accelerate scientific discovery and improve patient outcomes.
Side-by-side fundamentals
| Metric | AZTA | DHR | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $36.76 | $233.86 | |
| Market cap | $1.6B | $164.4B | |
| P/E as of 2026-10-21 | n/a | 41.54 | |
| Net margin FY2025, SEC XBRL | -9.4% | +14.7% | DHR higher |
| Gross margin FY2025, SEC XBRL | +45.5% | +59.1% | DHR higher |
| Operating margin FY2025, SEC XBRL | -4.5% | +19.1% | DHR higher |
| ROE FY2025, SEC XBRL | -3.3% | +6.9% | DHR higher |
| ROA FY2025, SEC XBRL | -2.7% | +4.3% | DHR higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-26 | n/a | 0.51 | |
| Revenue growth (YoY) FY2025, SEC XBRL | +3.5% | +2.9% | AZTA higher |
| Revenue CAGR (3y) SEC XBRL | +2.2% | -2.7% | AZTA higher |
| Dividend yield as of 2026-09-03 | n/a | +0.8% | |
| Dividend streak (yrs) SEC XBRL | 1 | n/a | |
| Beta as of 2026-09-03 | 1.38 | 0.78 | |
| 1-year return as of 2026-10-21 close | +15.6% | +5.9% | AZTA higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.